title: Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix.
abstract: Biofilm-associated polymicrobial infections, particularly those involving fungi and bacteria, are responsible for significant morbidity and mortality and tend to be challenging to treat. Candida albicans and Staphylococcus aureus specifically are considered leading opportunistic fungal and bacterial pathogens, respectively, mainly due to their ability to form biofilms on catheters and indwelling medical devices. However, the impact of mixed-species biofilm growth on therapy remains largely understudied. In this study, we investigated the influence of C. albicans secreted cell wall polysaccharides on the response of S. aureus to antibacterial agents in biofilm. Results demonstrated significantly enhanced tolerance for S. aureus to drugs in the presence of C. albicans or its secreted cell wall polysaccharide material. Fluorescence confocal time-lapse microscopy revealed impairment of drug diffusion through the mixed biofilm matrix. Using C. albicans mutant strains with modulated cell wall polysaccharide expression, exogenous supplementation, and enzymatic degradation, the C. albicans-secreted β-1,3-glucan cell wall component was identified as the key matrix constituent providing the bacteria with enhanced drug tolerance. Further, antibody labeling demonstrated rapid coating of the bacteria by the C. albicans matrix material. Importantly, via its effect on the fungal biofilm matrix, the antifungal caspofungin sensitized the bacteria to the drugs. Understanding such symbiotic interactions with clinical relevance between microbial species in biofilms will greatly aid in overcoming the limitations of current therapies and in defining potential new targets for treating polymicrobial infections.
  
  
  
  The fungus Candida albicans and the bacterium Staphylococcus aureus are important microbial pathogens responsible for the majority of infections in hospitalized patients and are often coisolated from a host. In this study, we demonstrated that when grown together, the fungus provides the bacterium with enhanced tolerance to antimicrobial drugs. This process was mediated by polysaccharides secreted by the fungal cell into the environment. The biofilm matrix formed by these polysaccharides prevented penetration by the drugs and provided the bacteria with protection. Importantly, we show that by inhibiting the production of the fungal polysaccharides, a specific antifungal agent indirectly sensitized the bacteria to antimicrobials. Understanding the therapeutic implications of the interactions between these two diverse microbial species will aid in overcoming the limitations of current therapies and in defining new targets for treating complex polymicrobial infections.
authors.affiliation: Graduate Program in Life Sciences, Molecular Microbiology and Immunology Program, University of Maryland, Baltimore, Maryland, USA Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, Maryland, USA.
authors.forename: Eric F
authors.initials: EF
authors.lastname: Kong
authors.affiliation: Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, Maryland, USA.
authors.forename: Christina
authors.initials: C
authors.lastname: Tsui
authors.affiliation: Laboratory of Molecular Cell Biology, KU Leuven, Leuven-Heverlee, Flanders, Belgium Department of Molecular Microbiology, VIB, Leuven-Heverlee, Flanders, Belgium.
authors.forename: Sona
authors.initials: S
authors.lastname: Kucharíková
authors.affiliation: Department of Medicine, Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, USA.
authors.forename: David
authors.initials: D
authors.lastname: Andes
authors.affiliation: Laboratory of Molecular Cell Biology, KU Leuven, Leuven-Heverlee, Flanders, Belgium Department of Molecular Microbiology, VIB, Leuven-Heverlee, Flanders, Belgium.
authors.forename: Patrick
authors.identifier: 0000-0002-1542-897X
authors.initials: P
authors.lastname: Van Dijck
authors.affiliation: Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, Maryland, USA mrizk@umaryland.edu.
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Jabra-Rizk
mesh_terms: D000900:Anti-Bacterial Agents / Q000378:metabolism*; D018441:Biofilms / Q000254:growth & development*; D002176:Candida albicans / Q000502:physiology*; D004361:Drug Tolerance; D056265:Microbial Interactions; D050296:Microbial Viability / Q000187:drug effects*; D018613:Microscopy, Confocal; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000502:physiology; D059008:Time-Lapse Imaging
chemical_list: D000900:Anti-Bacterial Agents